A Win For Obalon Therapeutics, Inc.
Mon, May 10, 2021 at 05:30 PM
Obalon Therapeutics, Inc. (OBLN:NASDAQ) soared at $2.87, a gain of 30.5%. The stock appeared on our News Catalysts scanner on Fri, Apr 23, 2021 at 04:29 PM in the 'INVESTOR UPDATE' category. From Fri, Apr 23, 2021, the stock recorded 20.00% Up Days and 36.36% Green Days
The stock spiked on Tue, Apr 20, 2021 at $3.14 with a volume of 22M+.
About Obalon Therapeutics, Inc. (OBLN:NASDAQ)
Obalon Therapeutics Inc is a commercial-stage medical device company focused on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss.
Top 10 Gainers:
- RTPY (RTPY:NASDAQ), 100%
- Tecnoglass Inc. (TGLS:NASDAQ), 30.96%
- Obalon Therapeutics, Inc. (OBLN:NASDAQ), 30.45%
- Cue Biopharma, Inc. (CUE:NASDAQ), 27.71%
- Soliton, Inc. (SOLY:NASDAQ), 24.5%
- ALF (ALF:NASDAQ), 23.51%
- PolarityTE, Inc. (PTE:NASDAQ), 23.18%
- Exterran Corporation (EXTN:NYSE), 21.81%
- UCL (UCL:NASDAQ), 21.4%
- Live Ventures Incorporated (LIVE:NASDAQ), 20.03%